# Kangying Redberry

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kangying-redberry

- Industry: Biotechnology
- Headquarters: Zhongshan, China
- Website: www.ky-rubyberries.com
- Latest round: Series A (Jun 5, 2024)
- Investors on record: 1

## About

Founded in 2020 in Zhongshan, China, Kangying Redberry (Fangchenggang) Biotechnology Co., Ltd. focuses on developing enzyme-based solutions. In June 2025, Kangying Redberry raised Series A funding from new investor Tsinghua Venture Capital.
Kangying Redberry specializes in biocatalysis, utilizing enzyme technology to provide solutions that tackle industrial challenges. Their enzyme products enhance efficiency in sectors such as food production, pharmaceuticals, and renewable energy, helping clients achieve better yields and reduced processing times.
Kangying Redberry generates revenue through direct sales of enzyme products primarily to clients in the food and beverage sector and pharmaceutical companies. They operate on a B2B model, offering tailored enzyme solutions, with potential pricing agreements that include bulk discounts. Their flagship products are designed to address specific industry needs, contributing significantly to their revenue streams.

## Funding rounds

- Series A, Jun 5, 2024 — Tsinghua Venture Capital

## Investors

- Tsinghua Venture Capital (https://capitalatlas.ai/funds/tsinghua-venture-capital) — Series A